A new risk calculator developed by researchers at the Mayo Clinic can estimate a person’s chance of developing mild cognitive impairment or dementia up to 10 years before symptoms appear. The tool uses biological markers rather than guesswork and is based on one of the largest long-term studies of brain aging.
The analysis draws from the Mayo Clinic Study of Aging, a community-based project that has tracked thousands of adults for nearly two decades. For this study, researchers evaluated about 5,900 cognitively healthy adults using four major predictors: age, sex, the APOE ε4 genotype, and brain amyloid levels measured with PET scans. Using these inputs, scientists estimated each person’s 10-year and lifetime risk of developing mild cognitive impairment or dementia. The team continues to track participants even after they leave the study, using medical records, which helps avoid losing data on people most likely to decline. In fact, dementia occurred twice as often among participants who dropped out compared with those who stayed.
What the study found
Three key findings emerged from the analysis. First, brain amyloid was the strongest predictor of future decline. Amyloid proteins begin accumulating silently in the brain decades before cognitive changes appear. People with higher amyloid levels had significantly greater 10-year and lifetime risk across all ages, sexes, and genetic backgrounds. Among 75-year-old APOE ε4 carriers, the lifetime risk of mild cognitive impairment jumped from 56% with low amyloid to over 80% with high amyloid.
Second, women carried a higher lifetime risk of mild cognitive impairment and dementia than men. This matches long-standing patterns seen in epidemiological studies. The reasons include hormonal shifts, immune differences, and longer life expectancy.
Third, genetics still matter, especially the APOE ε4 gene. Carriers of this gene had higher risk across all ages and amyloid levels. Amyloid amplified genetic vulnerability, suggesting that genes and brain biology interact long before symptoms appear.
Actionable steps for prevention
Researchers say the future of Alzheimer’s care will involve early detection long before memory changes occur. Tools like this risk calculator could guide when someone should consider amyloid-lowering therapies or intensify lifestyle changes.
Daily habits still shape long-term brain health. Decades of research point to the same protective factors: building and maintaining cardiorespiratory fitness, supporting metabolic health, getting high-quality sleep, eating a nutrient-rich diet, staying socially connected, and continuing to learn new things. These habits are linked to stronger cognition and slower decline.
Personalized prevention is coming. This risk tool remains a research instrument, but it points toward a future where brain health is measured individually, much like cholesterol and coronary calcium scores reshaped heart-disease prevention.
The takeaway
This study does not predict any person’s future with certainty, but it provides a clearer map of who is at highest risk long before symptoms begin. That clarity creates opportunity for earlier choices, earlier therapies, and earlier intervention.
